STRATA Skin Sciences, Inc. (SSKN) Asset Writedowns and Impairment (2013 - 2025)

STRATA Skin Sciences has reported Asset Writedowns and Impairment for 13 years, with the latest figure at $13000.0 in Q4 2025.

• Quarterly Asset Writedowns and Impairment rose 109.15% year-over-year to $13000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129000.0 (up 170.88% YoY) and the FY2025 annual result came in at $129000.0, up 170.88% from the prior year.
• Asset Writedowns and Impairment advanced to $13000.0 in Q4 2025 per SSKN's latest filing, from -$50000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $205000.0 in Q4 2023 and troughed at -$205000.0 in Q3 2023.
• A 5-year average of $2750.0 and a median of $13000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 700.0% in 2021, down 2800.0% in 2021.
• Over 5 years, Asset Writedowns and Impairment stood at $27000.0 in 2021, then soared by 207.41% to $83000.0 in 2022, then soared by 146.99% to $205000.0 in 2023, then tumbled by 169.27% to -$142000.0 in 2024, then jumped by 109.15% to $13000.0 in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $13000.0, -$50000.0, and $56000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.